Press release
Rising Chronic Conditions Is A Catalyst For Growth In The Extended-Release Drug Market: Powering Innovation and Expansion in the Extended-Release Drugs Market by 2025
Extended-Release Drugs Market
What Is the Expected CAGR for the Extended-Release Drugs Market Through 2025?
The market for extended-release drugs has seen a significant expansion in recent years. Its size is predicted to increase from $63.11 billion in 2024 to $69.63 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this upsurge in the historical phase include better patient adherence, the prevalence of chronic ailments, enhanced efficiency, strategies for patent protection, and biodegradable implants.
What's the Projected Size of the Global Extended-Release Drugs Market by 2029?
The market size for extended-release drugs is forecasted to experience swift expansion in the coming years, expanding to "$111.26 billion in 2029 with a compound annual growth rate (CAGR) of 12.4%. This projected growth during the forecast period can be credited to factors such as the adoption of personalized medicine strategies, the focus on patient-oriented drug development, the increasing prevalence of lifestyle-related diseases, drug repositioning, and worldwide access to extended-release therapies. Key trends predicted for the forecast period encompass pharmaceutical innovation, drug delivery system advancements, progress in nanotechnology, the application of 3d printing to drug formulation, the implementation of artificial intelligence, and environmental sustainability.
View the full report here:
https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report
Top Growth Drivers in the Extended-Release Drugs Industry: What's Accelerating the Market?
The extended-release drug market is expected to grow due to the rising prevalence of chronic conditions. Chronic conditions are illnesses that persist for at least one year, requiring continuous medical care, hindering daily activities, or both. They include diseases such as heart disease, cancer, obesity, and diabetes. Extended-release drug delivery systems are meant to maintain a steady level of medication in the body for a prolonged period. This helps to uphold a uniform therapeutic effect and prevent the ups and downs in drug levels seen with immediate-release medicines. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, forecasted that by 2050, there would be a 99.5% increase in people aged 50 and above suffering from at least one chronic illness, rising to 142.66 million. Therefore, the escalating prevalence of chronic conditions is fueling the growth of the extended-release drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12675&type=smp
What Are the Key Trends Driving Extended-Release Drugs Market Growth?
The extended-release drug market is witnessing a significant increase in product innovation-centric trends, with prominent businesses focusing on developing innovative products to maintain their market foothold. Notably, Zydus Pharmaceuticals (USA) Inc., a generic pharmaceutical manufacturer based in the US, introduced Topiramate extended-release capsules for epilepsy in July 2022. The company had previously gained approval from the US Food and Drug Administration (USFDA) to market Topiramate extended-release capsules, USP 25 mg, 50 mg, and 100 mg. This made it the first entity nationwide to get ultimate approval and roll out Topiramate extended-release capsules. These tablets have gained approval for individuals dealing with partial onset or primary generalized tonic-clinic seizure in two different ways.
What Are the Main Segments in the Extended-Release Drugs Market?
The extended-release drugs market covered in this report is segmented -
1) By Type: Sustained Release Drug, Controlled Release Drug
2) By Mode: Over-The-Counter, Prescription
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores
Subsegments:
1) By Sustained Release Drug: Matrix Systems, Coating Systems
2) By Controlled Release Drug: Osmotic Systems, Microencapsulation Systems, Targeted Delivery Systems
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12675&type=smp
Which Top Companies are Driving Growth in the Extended-Release Drugs Market?
Major companies operating in the extended-release drugs market include Pfizer Inc., AbbVie Inc., Novartis AG, Sanofi SA, GlaxoSmithKline PLC, AstraZeneca Plc, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals Inc., Eastman Chemical Company, Catalent Pharma Solutions Inc., Sun Pharmaceutical Industries Limited, Purdue Pharma LP, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Mallinckrodt LLC, Allergan plc, Hisamitsu Pharmaceutical Co. Inc., Janssen Pharmaceuticals Inc., Noven Pharmaceuticals Inc., Mayne Pharma Group Ltd., Neos Therapeutics Inc., Ardena Holding NV, UPM Pharmaceuticals Inc., Oakwood Laboratories LLC, Roxane Laboratories Inc., Lavipharm Laboratories Inc., Watson Pharmaceuticals Inc.
Which Regions Will Dominate the Extended-Release Drugs Market Through 2029?
North America was the largest region in the extended-release drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the extended-release drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12675
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Chronic Conditions Is A Catalyst For Growth In The Extended-Release Drug Market: Powering Innovation and Expansion in the Extended-Release Drugs Market by 2025 here
News-ID: 4180442 • Views: …
More Releases from The Business Research Company
Key Drivers Reshaping the Purvalanol A (CDK Inhibitor) Market: Increasing Preval …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Purvalanol A (CDK Inhibitor) Market Size Growth Forecast: What to Expect by 2025?
The market size for purvalanol A (CDK inhibitor) has witnessed a substantial expansion in the past few years. It is projected to escalate from $0.58 billion in 2024 to $0.64 billion in 2025, with a compound…
Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Polygenic Risk Score Services Market Size Growth Forecast: What to Expect by 2025?
The market size for polygenic risk score services has seen considerable growth in recent years. Anticipated to increase from $1.24 billion in 2024 to $1.45 billion in 2025, it projects a compound annual growth rate (CAGR)…
Future of the Global Pharmaceutical Unit-Dose Packaging Market: Trends, Innovati …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharmaceutical Unit-Dose Packaging Market Size Growth Forecast: What to Expect by 2025?
The market size of the pharmaceutical unit-dose packaging industry has experienced quick expansion in the recent past. The market, valued at $48.78 billion in 2024, is projected to rise to $54.50 billion in 2025, reflecting a compound…
Personal Care Product Testing Market Poised to Hit $10.37 Billion by 2029 with A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personal Care Product Testing Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the market size for personal care product testing has seen robust growth. It's projected to increase from $7.28 billion in 2024 to $7.84 billion in 2025, with a compound annual growth…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
